Hwaseong-si, South Korea

Su Yeon Park

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.6

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovations of Su Yeon Park

Introduction

Su Yeon Park is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of biocompatible materials and protein drugs. With a total of three patents to his name, his work focuses on enhancing the efficacy and duration of physiological activity of polypeptides.

Latest Patents

One of his latest patents is titled "Protein complex comprising non-peptidyl polymer-coupled fatty acid derivative compound as linker and preparation method therefor." This invention provides a protein conjugate that links a physiologically active polypeptide to a biocompatible material via a non-peptidyl polymer-coupled fatty acid derivative compound. This innovative approach has been shown to increase the serum half-life of the polypeptide, making it a valuable asset in the field of protein drugs. Another significant patent is "Non-peptidic polymeric linker compound, conjugate comprising same linker compound, and methods for preparing same linker compound and conjugate." This invention introduces a compound that allows for the binding of a functional group to a globulin Fc region or a physiologically active polypeptide, enhancing the versatility of polypeptide conjugates.

Career Highlights

Su Yeon Park is currently employed at Hanmi Pharm. Co., Ltd., where he continues to innovate in the pharmaceutical industry. His work has been instrumental in developing new methods and compounds that improve the effectiveness of protein-based therapies.

Collaborations

He collaborates with talented coworkers, including Dae Jin Kim and Ji Young Song, who contribute to the research and development efforts at Hanmi Pharm. Co., Ltd.

Conclusion

Su Yeon Park's innovative work in the field of biocompatible materials and protein drugs showcases his commitment to advancing medical science. His patents reflect a deep understanding of the complexities of protein interactions and their applications in therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…